Fortem Financial Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.08M Buy
3,953
+206
+5% +$116K 0.42% 64
2026
Q1
$2.11M Buy
3,747
+690
+23% +$442K 0.53% 59
2025
Q4
$2.07M Buy
+3,057
New +$2.08M 0.55% 53

Other funds holding IDXX

Fortem Financial Group's IDXX Position: Q2 2026 in Review

Fortem Financial Group increased its Idexx Laboratories (IDXX) stake by 5.5% in Q2 2026, buying an estimated $116K and bringing the position to 3,953 shares worth $2.08M. The position accounts for 0.42% of the portfolio, ranked #64.

Fortem Financial Group first reported a position in IDXX in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.11M in Q1 2026. 330 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Fortem Financial Group held 3,953 shares of Idexx Laboratories worth $2.08M as of Q2 2026.
  • Fortem Financial Group bought 206 Idexx Laboratories shares in Q2 2026, an estimated $116K.
  • Idexx Laboratories made up 0.42% of Fortem Financial Group's portfolio in Q2 2026, its #64 holding.
  • Fortem Financial Group first reported a position in Idexx Laboratories in Q4 2025 and has held it in 3 quarters since.
  • Fortem Financial Group's Idexx Laboratories position peaked at $2.11M in Q1 2026.
  • 330 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Fortem Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.